1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Veterinary Vaccines Market – By Vaccine Type

1.3.2        Europe Veterinary Vaccines Market – By Technology

1.3.3        Europe Veterinary Vaccines Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Veterinary Vaccines Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Veterinary Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidences of Zoonotic Diseases

5.1.2        Increasing Prevalence of Foodborne Diseases and Infections

5.2         Market Restraints

5.2.1        Strict Government Rules Related to Usage of Veterinary Vaccines

5.3         Market Opportunities

5.3.1        Escalating Growth in Untapped Economies

5.4         Future Trends

5.4.1        Increasing Awareness of Diagnosis and Treatment of Variety of Infectious Diseases

5.5         Impact Analysis

6.           Veterinary Vaccines Market– Europe Analysis

6.1         Europe Veterinary Vaccines Market Revenue Forecast and Analysis

7.           Europe Veterinary Vaccines Market Revenue and Forecasts to 2028– By Vaccine Type

7.1         Overview

7.2         Europe Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)

7.3         Livestock Vaccines

7.3.1        Overview

7.3.2        Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.3.3        Bovine Vaccines

7.3.3.1          Overview

7.3.3.2          Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.3.4        Small Ruminant Vaccines

7.3.4.1          Overview

7.3.4.2          Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Companion Vaccines

7.4.1        Overview

7.4.2        Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3        Feline Vaccines

7.4.3.1          Overview

7.4.3.2          Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4        Canine Vaccines

7.4.4.1          Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5        Other Companion Animal Vaccines

7.4.5.1          Overview

7.4.5.2          Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Others:

7.5.1        Overview

7.5.2        Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Veterinary Vaccines Market Revenue and Forecasts to 2028 – By Technology

8.1         Overview

8.2         Europe Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)

8.3         Live Attenuated Vaccines

8.3.1        Overview

8.3.2        Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.4         Inactivated Vaccines

8.4.1        Overview

8.4.2        Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.5         Toxoid Vaccines

8.5.1        Overview

8.5.2        Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.6         Recombinant Vaccines

8.6.1        Overview

8.6.2        Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Veterinary Vaccines Market Revenue and Forecasts to 2028 – Country Analysis

9.1         Europe: Veterinary Vaccines Market Revenue and Forecasts to 2028

9.1.1        Overview

9.1.3        Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)

9.1.3.1          Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.3.1.1          Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.3.1.2          Germany Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)

9.1.3.1.2.1        Germany: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.3.1.2.2        Germany: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.3.1.3          Germany: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.3.2          France Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

9.1.3.2.1          France: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2          France Veterinary Vaccines : Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.3.2.2.1        France: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.3.2.2.2        France: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.3.2.3          France: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.3.3          UK: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.1          UK: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.2          UK: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.3.3.2.1        UK: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.3.3.2.2        UK: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.3.3.3          UK: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.3.4          Italy: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.1          Italy: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.2          Italy: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.3.4.2.1        Italy: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.3.4.2.2        Italy: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.3.4.3          Italy: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.3.5          Spain: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.1          Spain: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.2          Spain: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.3.5.2.1        Spain: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.3.5.2.2        Spain: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.3.5.3          Spain: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.3.6          Rest of Europe: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.1          Rest of Europe: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.2          Rest of Europe: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.3.6.2.1        Rest of Europe: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.3.6.2.2        Rest of Europe: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.3.6.3          Rest of Europe: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

10.        Impact of COVID-19 Pandemic on Europe Veterinary Vaccines Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Zoetis Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Merck & Co., Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Virbac

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      BIOVAC

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      NEOGEN Corporation

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Elanco

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      HIPRA

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Ceva

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Hester Biosciences Limited

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Veterinary Vaccines Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2.             Germany Veterinary Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type(US$ Mn)

Table 3.             Germany Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 4.             Germany Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 5.             Germany Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 6.             France: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 7.             France Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 8.             France Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 9.             France Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 10.          UK: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 11.          UK Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 12.          UK: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 13.          UK: Veterinary Vaccines Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 14.          Italy: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 15.          Italy Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 16.          Italy Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 17.          Italy Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 18.          Spain: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 19.          Spain Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 20.          Spain Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 21.          Spain Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Europe: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Europe Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Europe Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Europe Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments Done by Companies

Table 27.          Inorganic Developments Done by Companies

Table 28.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Europe Veterinary Vaccines Market Segmentation

Figure 2.           Europe Veterinary Vaccines Market, By Country

Figure 3.           Europe Veterinary Vaccines Market Overview

Figure 4.           Livestock Vaccines Segment Held the Largest Share of the Market in 2021

Figure 5.           The UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to Europe Veterinary Vaccines Market

Figure 9.           Europe Veterinary Vaccines Market – Forecast and Analysis to 2028

Figure 10.        Europe Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)

Figure 11.        Europe Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Europe Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Europe Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Europe Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Europe Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Europe Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Europe Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Europe Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)

Figure 20.        Europe Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Europe Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Europe Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        Europe Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.        Europe Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Europe: Veterinary Vaccines Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 26.        Europe Veterinary Vaccines Market Revenue and Forecasts to 2028, By Country (%)

Figure 27.        Germany Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        France: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        UK: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Italy: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Spain: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Rest of Europe: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Impact Of COVID-19 Pandemic in Europe Country Markets

CONTACT US

If you have any queries about this report or would like further information, please contact us:

North America:            +1 646 491 9876

Asia-Pacific:                +91 20 6727 8686

Email:                          info@theinsightpartners.com

DISCLAIMER

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”.